VRNS vs PATH โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
PATH Captures Institutional Edge (2โ2 Pillars ยท 7โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to UiPath, Inc. (PATH) driven by superior Valuation, Growth & Margin while VRNS counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, VRNS trades at 114.9x Forward P/E with -22.5% operating margin (+17.3% YoY revenue) versus PATH at 17.4x Forward P/E and 9.4% operating margin (+13.4% YoY). In options structure, VRNS sits in CONSOLIDATION (3rd %ile IV; Dealer Gamma Walls on Pro) against PATH sits in BREAKDOWN (11th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | VRNS Revenue | PATH Revenue | VRNS Op. Margin | PATH Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2019 | $250M | N/A | -29.9% | N/A | VRNS |
| FY2020 | $290M | $340M | -26.8% | -153.9% | VRNS |
| FY2021 | $390M | $610M | -25.3% | -18.2% | PATH |
| FY2022 | $470M | $890M | -25.6% | -56.1% | VRNS |
| FY2023 | $500M | $1.06B | -23.5% | -32.9% | VRNS |
| FY2024 | $550M | $1.31B | -21.4% | -12.6% | PATH |
| FY2025 | $620M | $1.43B | -23.5% | -11.4% | PATH |
| FY2026 | N/A | $1.61B | N/A | 3.5% | PATH |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | VRNS | PATH | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $5.7B | $6.8B | Larger Scale | PATH |
| Trailing P/E Ratio Valuation | 142.9x | 19.6x | Lower Multiple | PATH |
| Forward P/E Ratio Valuation | 114.9x | 17.4x | Lower Multiple | PATH |
| Revenue Growth (YoY) Growth | +17.3% | +13.4% | Higher Growth | VRNS |
| Operating Margin (TTM) Profitability | -22.5% | 9.4% | Higher Margin | PATH |
| Net Profit Margin Profitability | -21.4% | 21.0% | Higher Margin | PATH |
| Return on Equity (ROE) Capital Efficiency | -29.5% | 20.0% | Higher ROE | PATH |
| 52-Week Range Position Momentum | 96% ($20โ$50) | 38% ($9โ$20) | Stronger Trend | VRNS |
| Beta / 30D Volatility Risk Regime | 0.52ฮฒ ยท 4% Vol | 0.86ฮฒ ยท 30% Vol | Lower Realized Risk | VRNS |
| Unified Institutional Score Composite Signal | 51.3 / 100 (HOLD) | 58.3 / 100 (HOLD) | Higher Composite | PATH |